Talia M Nir,Jean-Paul Fouche,Jintanat Ananworanich,Beau M Ances,Jasmina Boban,Bruce J Brew,Joga R Chaganti,Linda Chang,Christopher R K Ching,Lucette A Cysique,Thomas Ernst,Joshua Faskowitz,Vikash Gupta,Jaroslaw Harezlak,Jodi M Heaps-Woodruff,Charles H Hinkin,Jacqueline Hoare,John A Joska,Kalpana J Kallianpur,Taylor Kuhn,Hei Y Lam,Meng Law,Christine Lebrun-Frénay,Andrew J Levine,Lydiane Mondot,Beau K Nakamoto,Bradford A Navia,Xavier Pennec,Eric C Porges,Lauren E Salminen,Cecilia M Shikuma,Wesley Surento,April D Thames,Victor Valcour,Matteo Vassallo,Adam J Woods,Paul M Thompson,Ronald A Cohen,Robert Paul,Dan J Stein,Neda Jahanshad

Abstract:Importance: Despite more widely accessible combination antiretroviral therapy (cART), HIV-1 infection remains a global public health challenge. Even in treated patients with chronic HIV infection, neurocognitive impairment often persists, affecting quality of life. Identifying the neuroanatomical pathways associated with infection in vivo may delineate the neuropathologic processes underlying these deficits. However, published neuroimaging findings from relatively small, heterogeneous cohorts are inconsistent, limiting the generalizability of the conclusions drawn to date. Objective: To examine structural brain associations with the most commonly collected clinical assessments of HIV burden (CD4+ T-cell count and viral load), which are generalizable across demographically and clinically diverse HIV-infected individuals worldwide. Design, setting, and participants: This cross-sectional study established the HIV Working Group within the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) consortium to pool and harmonize data from existing HIV neuroimaging studies. In total, data from 1295 HIV-positive adults were contributed from 13 studies across Africa, Asia, Australia, Europe, and North America. Regional and whole brain segmentations were extracted from data sets as contributing studies joined the consortium on a rolling basis from November 1, 2014, to December 31, 2019. Main outcomes and measures: Volume estimates for 8 subcortical brain regions were extracted from T1-weighted magnetic resonance images to identify associations with blood plasma markers of current immunosuppression (CD4+ T-cell counts) or detectable plasma viral load (dVL) in HIV-positive participants. Post hoc sensitivity analyses stratified data by cART status. Results: After quality assurance, data from 1203 HIV-positive individuals (mean [SD] age, 45.7 [11.5] years; 880 [73.2%] male; 897 [74.6%] taking cART) remained. Lower current CD4+ cell counts were associated with smaller hippocampal (mean [SE] β = 16.66 [4.72] mm3 per 100 cells/mm3; P < .001) and thalamic (mean [SE] β = 32.24 [8.96] mm3 per 100 cells/mm3; P < .001) volumes and larger ventricles (mean [SE] β = -391.50 [122.58] mm3 per 100 cells/mm3; P = .001); in participants not taking cART, however, lower current CD4+ cell counts were associated with smaller putamen volumes (mean [SE] β = 57.34 [18.78] mm3 per 100 cells/mm3; P = .003). A dVL was associated with smaller hippocampal volumes (d = -0.17; P = .005); in participants taking cART, dVL was also associated with smaller amygdala volumes (d = -0.23; P = .004). Conclusions and relevance: In a large-scale international population of HIV-positive individuals, volumes of structures in the limbic system were consistently associated with current plasma markers. Our findings extend beyond the classically implicated regions of the basal ganglia and may represent a generalizable brain signature of HIV infection in the cART era.

Association of Immunosuppression and Viral Load With Subcortical Brain Volume in an International Sample of People Living With HIV

Effects of perinatal HIV-infection on the cortical thickness and subcortical gray matter volumes in young adulthood

HIV Viral Transcription and Immune Perturbations in the CNS of People with HIV Despite ART

Altered Gray Matter Volume and Functional Connectivity in Human Immunodeficiency Virus-Infected Adults

Neurocognitive Dysfunction With Neuronal Injury in People With HIV on Long-Duration Antiretroviral Therapy

Effects of clinical, comorbid, and social determinants of health on brain ageing in people with and without HIV: a retrospective case-control study

Atypical Resting-State Functional Connectivity Dynamics Correlate With Early Cognitive Dysfunction in HIV Infection

Cerebral abnormalities in HIV-infected individuals with neurocognitive impairment revealed by fMRI

Structural and Functional Brain Abnormalities in Human Immunodeficiency Virus Disease Revealed by Multimodal Magnetic Resonance Imaging Fusion: Association With Cognitive Function

Multimodal Investigation of Neuroinflammation in Aviremic Patients With HIV on Antiretroviral Therapy and HIV Elite Controllers

Neurocognitive dysfunction in HIV-infected youth: investigating the relationship with immune activation

Symptomatic and Asymptomatic Neurocognitive Impairment, ART Adherence and HIV Control: A 4-Year Observational Study

Dynamics of peripheral T cell exhaustion and monocyte subpopulations in neurocognitive impairment and brain atrophy in chronic HIV infection

Brain Volumetric Alterations in Preclinical HIV-Associated Neurocognitive Disorder Using Automatic Brain Quantification and Segmentation Tool

Spatial Heterogeneity of Brain Lipids in SIV-Infected Macaques Treated with Antiretroviral Therapy

Association between brain volumes and HAND in cART-naïve HIV+ individuals from Thailand

White and Gray Matter Changes are Associated With Neurocognitive Decline in HIV Infection

Association between HIV and cytomegalovirus and neurocognitive outcomes among children with HIV

Altered gray matter structural covariance networks in drug-naïve and treated early HIV-infected individuals

Characterization of the brain virome in human immunodeficiency virus infection and substance use disorder

Cerebral regional and network abnormalities in HIV-infected with neurocognitive impairments: An fMRI study